Bruker Corporation

NasdaqGS:BRKR 株式レポート

時価総額:US$7.8b

Bruker 過去の業績

過去 基準チェック /26

Brukerは、平均年間16.3%の収益成長を遂げていますが、 Life Sciences業界の収益は、年間 成長しています。収益は、平均年間11.7% 10.2%収益成長率で 成長しています。 Brukerの自己資本利益率は16.5%であり、純利益率は9.4%です。

主要情報

16.3%

収益成長率

17.6%

EPS成長率

Life Sciences 業界の成長21.5%
収益成長率10.2%
株主資本利益率16.5%
ネット・マージン9.4%
前回の決算情報30 Sep 2024

最近の業績更新

Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Nov 14
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

May 09
Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

Recent updates

Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Nov 14
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Bruker: Still Challenged, Certainly Margins

Nov 02

Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

Oct 25
Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Sep 10
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In

Aug 22

Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 22
Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Jun 09
Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Bruker: A Confusing Acquisition Spree

May 31

Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

May 09
Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

Bruker Corporation: An Aggressive Acquisition Strategy

Apr 24

Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research

Apr 11

Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

Jan 22
Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Jan 08
There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Dec 26
Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Nov 06
Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Oct 23
Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Sep 25
Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Aug 09
Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 27
Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

Jul 11
Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

収支内訳

Bruker の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqGS:BRKR 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Sep 243,241305855356
30 Jun 243,120352804329
31 Mar 243,001402762308
31 Dec 232,965427730295
30 Sep 232,818319687275
30 Jun 232,715319644260
31 Mar 232,621312625248
31 Dec 222,531297608236
30 Sep 222,506275598231
30 Jun 222,476274605226
31 Mar 222,458282577223
31 Dec 212,418277563221
30 Sep 212,362270544220
30 Jun 212,264238518216
31 Mar 212,118204485204
31 Dec 201,988158472198
30 Sep 201,960158470188
30 Jun 201,970165480185
31 Mar 202,035177503190
31 Dec 192,073197500188
30 Sep 192,026207491186
30 Jun 191,972189473182
31 Mar 191,925184459177
31 Dec 181,896180449173
30 Sep 181,87398443172
30 Jun 181,84292440171
31 Mar 181,81384432167
31 Dec 171,76679420162
30 Sep 171,706151407157
30 Jun 171,664161399154
31 Mar 171,621152396151
31 Dec 161,611154394148
30 Sep 161,619146393148
30 Jun 161,621111393144
31 Mar 161,646119390145
31 Dec 151,624102392146
30 Sep 151,65466408151
30 Jun 151,67760420158
31 Mar 151,73955436165
31 Dec 141,80957451174
30 Sep 141,85366451182
30 Jun 141,87277449185
31 Mar 141,87083441187
31 Dec 131,83980438191

質の高い収益: BRKRは 高品質の収益 を持っています。

利益率の向上: BRKRの現在の純利益率 (9.4%)は、昨年(11.3%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: BRKRの収益は過去 5 年間で年間16.3%増加しました。

成長の加速: BRKRは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: BRKRは過去 1 年間で収益成長率がマイナス ( -4.5% ) となったため、 Life Sciences業界平均 ( -4.7% ) と比較することが困難です。


株主資本利益率

高いROE: BRKRの 自己資本利益率 ( 16.5% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘